YAN LIN: Open Payments
NPI 1831677178 · FLUSHING, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,162 in 61 payments from 17 companies in 2025. Trend: 2023 $2,050 · 2024 $1,681 · 2025 $2,162
Food & beverage: $2,162
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 17 | $619 |
| AstraZeneca Pharmaceuticals LP | 15 | $408 |
| Amgen Inc. | 6 | $340 |
| Medtronic, Inc. | 1 | $178 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $125 |
| Merck Sharp & Dohme LLC | 5 | $102 |
| Novo Nordisk Inc | 3 | $75 |
| Janssen Biotech, Inc. | 2 | $58 |
| RECORDATI_RARE_DISEASES_INC. | 2 | $53 |
| Lilly USA, LLC | 2 | $43 |
Products named: FARXIGA, SYMPLICITY G3, Otezla, REPATHA, AIRSUPRA, JARDIANCE, Livdelzi, KEYTRUDA.
Industry payments across NY — which companies pay providers there.
